Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock | 
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2  | 
			
|---|---|
| Purity | ≥98%  | 
			
| Formula | C17H12Cl2F3N7O2S  | 
			
| Formula Wt. | 506.30  | 
			
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide  | 
			
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble  | 
			
| Store Temp | -20°C  | 
			
|---|---|
| Ship Temp | Ambient  | 
			
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures | 
http://clinicaltrials.gov/show/NCT01425008
Isoxazole derivative; HSP90 inhibitor.
Ca2+-sensing receptor agonist.
Phenothiazine derivative; D1/2 and 5-HT1A/2A an...
STING inhibitor
AurK, FLT3, Abl inhibitor.
AR antagonist.
ALK and IGF-1R inhibitor.
Diterpene found in brewed, unfiltered coffee; F...
Calcium channel blocker.
Isoflavone, phytoestrogen found in soy; ER agon...
Acyl transfer catalyst, involved in peptide syn...
Thiazolidine macrolide found in the Red Sea spo...
Non-endogenous essential vitamin (B9), found in...
Akt inhibitor.
Amide form of vitamin B3 required for productio...
Fat-soluble vitamin C derivative.
Calcium channel blocker.
H+/K+ ATPase inhibitor.
Degrader of IKZF1/3
Azoxy compound